نتایج جستجو برای: monoclonal antibodies mab

تعداد نتایج: 184533  

Journal: :The Journal of pharmacology and experimental therapeutics 2004
D E McMillan W C Hardwick M Li M G Gunnell F I Carroll P Abraham S M Owens

Two murine-derived anti-methamphetamine monoclonal antibodies were studied as potential pharmacokinetic antagonists of (+)-methamphetamine self-administration by rats. Intravenous administration of a 1 g/kg dose of the lower affinity [antibody equilibrium dissociation constant (K(d)) = 250 nM] monoclonal antibody (mAb) designated mAb6H8, 1 day before the start of several daily 2-h self-administ...

Journal: :Asian Pacific journal of cancer prevention : APJCP 2012
Dong Duan Shao-Lin Li Yu-Quan Zhu Tao Zhang Cheng-Ming Lei Xiang-Hua Cheng

The present study was conducted to evaluate radioimmunoimaging (RII) and in vivo distribution of mixed antibodies 99mTc-EGFR-mAb and 99mTc-CD44- mAb in nude mice bearing human lung adenocarcinoma xenografts. Single and mixed applications of the two radiolabeled monoclonal antibodies (mAbs) were compared. Direct labeling of 99mTc was applied to radiolabel the EGFR and CD44 mAbs. The properties o...

Journal: :journal of agricultural science and technology 2010
h. massumi a. hosseini pour

a survey was carried out in five provinces of iran (kerman, sistan and baluchestan, hormozgan, khorasan and yazd) for the presence of alfalfa mosaic virus (amv) sero-types in alfalfa during 2002 to 2003. the number of samples collected was 250, represent-ing the diversity and geographical distribution of amv in these areas. diagnosis was car-ried out using polyclonal (pabs) and monoclonal (mabs...

Journal: :SynBio 2023

Rheumatoid arthritis (RA) is one of the most common autoimmune diseases, affecting 0.5% to 1% population. It could ultimately result in joint destruction, functional decline, work disability, and enhanced mortality. Cyclic citrullinated peptide antibodies (CCP Abs) are useful biomarkers for early detection diagnosis RA. In this study, we used plant viral-based expression vectors that produce ra...

Journal: :Journal of clinical microbiology 2001
M Rivera-Betancourt J E Keen

Two murine monoclonal antibodies (MAb), 2C5-F10 and 8D1-H10, reactive with Escherichia coli O4 and H5 antigens, respectively, were generated and characterized. Enzyme immunoassays and immunoblots demonstrated that MAb 2C5-F10 reacted specifically with lipopolysaccharide O antigen of E. coli O4 isolates, while MAb 8D1-H10 reacted with E. coli strains expressing H5 flagella.

2012
Roch Houot Holbrook Kohrt Ron Levy

Monoclonal antibodies (mAb) induce tumor regression through antibody-dependant cellular cytotoxicity (ADCC). We recently showed that an agonistic anti-CD137 mAb stimulates natural killer (NK) cells which have been activated by a tumor-specific mAb, resulting in increased ADCC against cancer cells.

Journal: :Mathematics 2023

The growth of colorectal cancer tumors and their reactions to chemo-immunotherapeutic treatment with monoclonal antibodies (mAb) are discussed in this paper using a system fractional order differential equations (FDEs). mAb medications still at the research stage; however, takes into account mAbs that already use. major goal is demonstrate effectiveness medication Cetuximab significance IL-2 le...

2014
Nuray Gül Liane Babes Paul Kubes Marjolein van Egmond

Monoclonal antibodies (mAbs) are increasingly being used to treat cancer. In response to mAb therapy, we have identified macrophages in the liver as major effector cells removing circulating tumor cells via antibody-dependent phagocytosis, an immune cell-mediated process that prevented liver metastasis. This discovery extends our understanding of the mechanisms of mAb therapy, and may help to o...

2016
Guillaume Desoubeaux Janice M. Reichert Matthew Sleeman Karen L. Reckamp Bernhard Ryffel Jörg P. Adamczewski Theresa D. Sweeney Rita Vanbever Patrice Diot Caroline A. Owen Clive Page Stéphanie Lerondel Alain Le Pape Nathalie Heuze-Vourc'h

Monoclonal antibody (mAb) therapeutics have tremendous potential to benefit patients with lung diseases, for which there remains substantial unmet medical need. To capture the current state of mAb research and development in the area of respiratory diseases, the Research Center of Respiratory Diseases (CEPR-INSERM U1100), the Laboratory of Excellence "MAbImprove," the GDR 3260 "Antibodies and t...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید